Home › Funds › CAPITOLIS LIQUID GLOBAL MARKETS LLC › ABBV

CAPITOLIS LIQUID GLOBAL MARKETS LLC position in ABBV

ABBVIE INC · Health Care

CAPITOLIS LIQUID GLOBAL MARKETS LLC reported holding 448,132 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$117.2M, representing 0.52% of its reported portfolio and ranking #44 among its reported holdings. CAPITOLIS LIQUID GLOBAL MARKETS LLC has disclosed ABBV holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)448.13K sh
Reported value held$117.23M
Portfolio Weight0.52%
First reportedQ4 2023
Last changeAdd
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How CAPITOLIS LIQUID GLOBAL MARKETS LLC's ABBV position evolved

CAPITOLIS LIQUID GLOBAL MARKETS LLC first disclosed a stake in ABBV in Q4 2023 at 110,000 shares (US$17.0M). The position peaked in Q3 2024 at 810,000 shares, worth US$160.0M. Across 12 filings, CAPITOLIS LIQUID GLOBAL MARKETS LLC increased the stake 4 time(s), trimmed it 5 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 448,132 shares valued at US$117.2M — an increase of 30,939 shares quarter over quarter.. Notable position changes include a 64% trim in Q1 2024 (shares fell 5% over the following quarter), a 1925% increase in Q3 2024 (shares fell 9% over the following quarter), a 38% trim in Q2 2026 (shares rose 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 110.00K $17.05M New
Q1 2024 40.00K $7.28M Reduce
Q2 2024 40.00K $6.86M Hold
Q3 2024 810.00K $159.96M Add
Q4 2024 650.00K $115.50M Reduce
Q1 2025 612.30K $128.29M Reduce
Q2 2025 642.30K $119.22M Add
Q3 2025 591.07K $136.86M Reduce
Q4 2025 673.32K $153.85M Add
Q1 2026 673.44K $146.47M Hold
Q2 2026 417.19K $104.98M Reduce
Q3 2026 448.13K $117.23M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 34 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$29.04B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has CAPITOLIS LIQUID GLOBAL MARKETS LLC held ABBV?

CAPITOLIS LIQUID GLOBAL MARKETS LLC has disclosed ABBV holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

What is CAPITOLIS LIQUID GLOBAL MARKETS LLC's current position in ABBV?

As of Q3 2026, CAPITOLIS LIQUID GLOBAL MARKETS LLC holds 448.13K shares of ABBV (ABBVIE INC), valued at $117.23M, representing 0.52% of its reported portfolio and ranking #44.

Has CAPITOLIS LIQUID GLOBAL MARKETS LLC been buying or selling ABBV?

In the latest 13F filing (Q3 2026), CAPITOLIS LIQUID GLOBAL MARKETS LLC increased its position in ABBV. The position peaked in Q3 2024 at 810.00K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.